FINANCIAL STATEMENTS      ANNUAL REPORT 2017      95
(a) Income tax (expense)/benefit
(i) Net tax (expense)/benefit
31 December
2017
$M
31 December
2016
$M
Income tax (expense)/benefit
(84)
73
Income tax over provision in respect of prior years
2
12
(82)
85
Net tax (expense)/benefit is attributable to:
Continuing operations
(82)
85
(ii) Income tax benefit
Deferred tax (expense)/benefit
(87)
85
Deferred tax (expense)/benefit included in income tax benefit comprises:
(Decrease)/increase in deferred tax assets (refer to Note B6(b)(i))
(73)
157
Increase/(decrease) in deferred tax liabilities (refer to Note B6(c)(i))
(9)
(70)
Movements in other including assets classified as held for sale
–
(2)
(82)
85
(iii) Reconciliation of income tax (expense)/benefit to prima facie tax payable
31 December
2017
$M
31 December
2016
$M
Profit/(loss) from continuing operations before tax
311
(312)
Tax at the Australian tax rate of 30% (2016 – 30%)
(95)
94
Tax effect of amounts which are not deductible/taxable in calculating taxable income:
Stamp duty provision expensed
(1)
(4)
Share of profit/(loss) of equity-accounted investees not deductible
10
(2)
Gain on acquisition of subsidiaries
2
–
Plant and equipment
–
8
Under/over provision in prior years
1
12
Denial of debt deductions
(1)
(19)
Other
2
(4)
Income tax (expense)/benefit
(82)
85
(iv) Amounts recognised directly in equity
Aggregate current and deferred tax arising in the reporting period and not recognised in net
profit or loss or other comprehensive income but directly debited or credited to equity:
Cash flow hedges
173
27
Subordinated Capital Note transaction costs
–
(1)
Entitlement offer issue costs
(20)
–
153
26